Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Change in Cash (2017 - 2020)

Historic Change in Cash for Monopar Therapeutics (MNPR) over the last 4 years, with Q3 2020 value amounting to $5.4 million.

  • Monopar Therapeutics' Change in Cash rose 95575.09% to $5.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $13.5 million, marking a year-over-year increase of 53179.64%. This contributed to the annual value of $38.6 million for FY2024, which is 428972.09% up from last year.
  • As of Q3 2020, Monopar Therapeutics' Change in Cash stood at $5.4 million, which was up 95575.09% from -$46173.0 recorded in Q2 2020.
  • Over the past 5 years, Monopar Therapeutics' Change in Cash peaked at $8.7 million during Q4 2019, and registered a low of -$1.0 million during Q1 2019.
  • Moreover, its 4-year median value for Change in Cash was -$621567.0 (2020), whereas its average is $1.0 million.
  • As far as peak fluctuations go, Monopar Therapeutics' Change in Cash tumbled by 21920.85% in 2018, and later soared by 130185.71% in 2019.
  • Over the past 4 years, Monopar Therapeutics' Change in Cash (Quarter) stood at -$806020.0 in 2017, then rose by 9.99% to -$725493.0 in 2018, then skyrocketed by 1301.86% to $8.7 million in 2019, then crashed by 37.65% to $5.4 million in 2020.
  • Its last three reported values are $5.4 million in Q3 2020, -$46173.0 for Q2 2020, and -$621567.0 during Q1 2020.